drugset
Drugs / Helium
last change Jul 2013 re-read 2 minutes ago

Helium

also known as E-939 · Helium-4 · INS NO.939 · INS-939

Small molecule

Developed for
chronic obstructive pulmonary disease
Investigated by
Nova Scotia Health Authority · University of Saskatchewan

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) HELIUM, USP — 2013-07-14 fda.gov ↗

Trials 1 · a red edge is where a trial was stopped

today
US approved 2013
NCT00394225 · not/applicable
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00394225 Jul 2005 → May 2006 chronic obstructive pulmonary disease University of Saskatchewan Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Helium ClinicalTrials.gov intervention name — accepted as the source's own label NCT00394225 ↗
Known as E-939 ChEMBL registry synonym — accepted as the source's own label CHEMBL1796997 ↗
Known as Helium-4 ChEMBL registry synonym — accepted as the source's own label CHEMBL1796997 ↗
Known as INS NO.939 ChEMBL registry synonym — accepted as the source's own label CHEMBL1796997 ↗
Known as INS-939 ChEMBL registry synonym — accepted as the source's own label CHEMBL1796997 ↗
Modality Small molecule — CHEMBL1796997 ↗